This study published in the journal Nutrients compared the effect of peanuts and almonds incorporated into a low carbohydrate diet (LCD) on cardio-metabolic and inflammatory markers in T2DM patients. In total, 32 participants were included in the study, 17 were allocated in the Peanut group and 15 to the Almond group. Participants consumed an LCD supplemented by peanuts (60 g/day for men and 50 g/day for women) or almonds (55 g/day for men and 45 g/day for women). The follow-ups were conducted once a week during the first month of the intervention, and once every two weeks in the second and third months. Results showed that peanut and almond intake did not increase the body mass index (BMI) and had no effect on the blood lipid profile, even though, incorporated into an LCD, they may help improve the fasting blood glucose and postprandial blood glucose in patients with T2DM.